AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Zai Lab to Participate in Investor Conferences in September 2025
ByAinvest
Thursday, Aug 28, 2025 7:34 am ET1min read
Zai Lab Limited will participate in investor conferences in September 2025, including the Cantor Global Healthcare Conference and Morgan Stanley 23rd Annual Global Healthcare Conference. Members of the company's senior management team will present at the events, and live webcasts will be available on the company's website. The conferences will focus on the company's research-based biopharmaceutical products in areas such as oncology, immunology, neuroscience, and infectious disease.
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a leading biopharmaceutical company, has announced its participation in two significant investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference and the Morgan Stanley 23rd Annual Global Healthcare Conference, both taking place in New York, NY.At the Cantor Global Healthcare Conference, scheduled for Thursday, September 4, 2025, at 10:20 a.m. ET, members of Zai Lab's senior management team will deliver a presentation. The Morgan Stanley conference, set for Tuesday, September 9, 2025, at 2:35 p.m. ET, will feature a fireside chat with the company's leadership. Live webcasts of both events will be available on Zai Lab's Investor Relations page at ir.zailaboratory.com/webcasts-presentations, with archived replays accessible for up to 90 days following the events.
Zai Lab, based in China and the United States, is focused on discovering, developing, and commercializing innovative products that address unmet medical needs in oncology, immunology, neuroscience, and infectious disease. The company's portfolio includes several patented drug candidates, such as ZEJULA, OPTUNE, QINLOCK, NUZYRA, and VYVGART, among others.
This announcement follows Zai Lab's recent financial performance, where the company reported a narrowing loss in the first half of 2025, accompanied by a 15% increase in revenue [2].
References:
[1] https://www.stocktitan.net/news/ZLAB/zai-lab-announces-participation-in-investor-conferences-in-september-ujp2jo4end69.html
[2] https://www.marketscreener.com/news/zai-lab-s-loss-narrows-in-h1-as-revenue-jumps-15-ce7c50d8df88ff26
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet